この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2016/2/181 分で読めます
Effective Date of Requirement for Premarket Approval for Total Metal-on-Metal Semi-Constrained Hip Joint Systems
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is issuing a final order to require the filing of a premarket approval application (PMA) or a notice of completion of a product development protocol (PDP) for the hip joint metal/metal semi-constrained, with a cemented acetabular component, prosthesis; and hip joint metal/metal semi-constrained, with an uncemented acetabular component, prosthesis.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →